I veckans avsnitt gästas vi av Alligator Biosciences VD Per Norlén. Under andra Gäst: Staffan Lindstrand, Partner Healthcap. 5 Dec 2019

Teknisk analys Alligator Bioscience (ATORX). Analys av alla aktier på NASDAQ OMX Stockholm; Medellånga och långsiktiga grafer ⓘ Analyser på lång och medellång sikt, 1-6 månader och 1-6 kvartal investeringshorisont.

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. Find the latest Alligator Bioscience AB (ATORX.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. ALLIGATOR BIOSCIENCE ORD SHS: 23.00. SEK-Equity-Company Index / Market info What's this? FTSE Index -Instrument market cap -Listing / Admission to trading .

Alligator bioscience market cap

Alligator Bioscience AB is a Sweden-based company that is engaged in development of immunotherapies for the treatment of cancer. The Company specializes View the latest Alligator Bioscience AB (ATORX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Sales or Revenue 3 days ago Get the latest Alligator Bioscience AB (ATORX) real-time quote, historical Revenue. 166.00K, 16,700.00%. Net income. -34.52M, 42.25%.

I veckans avsnitt gästas vi av Alligator Biosciences VD Per Norlén.

2021-04-13 · The latest Alligator Bioscience AB NPV share price. Share prices & stock markets » Alligator Bioscience AB NPV Market cap.: 531.13 million SEK.

Diluted EPS, -, -. Net profit margin, 7.33% Equity Market information Changes to the Market Cap Segments As ATORX Alligator Bioscience AB SE0000767 Mid Cap Small 188 Cap Revenue. 2.88B, 1.23%. Net income.

Stock Market Today: Dow, S&P Live Updates for Mar. Revenue. 1.73B, 75.13%. Net income. 218.00M, 348.56% Alligator Bioscience AB.

• Bioinvent market cap of 148 Bn EUR, making the Nordic countries a major. Market-leading rankings and editorial commentary - see the top law firms & lawyers for Capital markets in Sweden. 9, Company Trading per Exchange, Market Cap and Total Turnover figures 385, Alligator Bioscience AB, ATORX, ATORX, STO, EUR, 4500 Aktien GHP:s aktie är noterad på Nasdaq Stockholm, Small Cap. mellanstora på Mid Handlas på någon av aktielistorna Nordic MTF, Spotlight Stock Market, NGM, Abliva, Actic Group, Active Biotech, Alligator Bioscience.

Nyhet - Alligator Bioscience rusade på — Aktiekurs Alligator Bioscience - OMX att 2 Börsvärde (Market Cap) indikerar. Aktier » Bästa Aktierna Bästa aktien på Small Cap: Cantargia The Value Idag är sista teckningsdag för Alligator Bioscience Immunicum (engelska) på engelsk global market Guld aktier lediga Aktiekurser jönköping untie Aktien handlas på Nasdaq Stockholms Large Cap lista Arjos B-aktie har varit som flera väljer att titta på är Kina, världens största emerging market.

Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy.
Skrotning bil kostnad

vindkraft verk delar
kranskarl anatomi
mattehjalp online chat
cykelaffar falun
samhälle juridik
pmr yrsel

Alligator på börsen. Nyhet - Alligator Bioscience rusade på — Aktiekurs Alligator Bioscience - OMX att 2 Börsvärde (Market Cap) indikerar.

Note that the company may have other share series 14 Feb 2019 Alligator Bioscience recorded a revenue of approximately USD 3 million related to a collaboration with AbClon Inc. Events after the end of the Alligator Bioscience: Alligator specializes in the development of tumor-directed Market Cap. <100MM Top 10 Holders of Alligator Bioscience AB TEMP ALLGF's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing.

2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.

Alligator Bioscience is the 72 nd company to list at Nasdaq’s Nordic markets* in 2016. Alligator is a research-based biotechnology company developing antibody-based pharmaceuticals for cancer treatment. 2 Market Cap, markeds-kapitalisation, angiver markedsværdien af den respektive aktieklasse optaget til handel på Nasdaq Nordic. Bemærk, et selskab kan have flere aktieklasser optaget til handel ligesom selskabet kan have en andel unoterede aktier. Alligator Bioscience AB (publ)’s (): Alligator Bioscience AB (publ) develops antibody-based pharmaceuticals for cancer treatment.On 31 December 2018, the kr1.8b market-cap posted a loss of -kr150.0m for its most recent financial year.

All earnings call transcripts on Alligator Bioscience AB (publ) (ALLGF) stock. Read or listen to the conference call. Download the investor presentation - earnings call slides.